Trials / Completed
CompletedNCT00102232
Effect of Phosphatidylcholine on Plasma Homocysteine in Healthy Volunteers
Effect of Choline Supplemented as Phosphatidylcholine on Post-Methionine Loading and Fasting Concentrations of Plasma Homocysteine in Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (planned)
- Sponsor
- Wageningen Centre for Food Sciences · Academic / Other
- Sex
- Male
- Age
- 50 Years – 71 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether supplementation with phosphatidylcholine lowers plasma homocysteine concentrations in healthy men.
Detailed description
A high homocysteine concentration is a potential risk for cardiovascular disease. Plasma homocysteine concentrations can be lowered through betaine supplementation. However, effects of choline supplementation, the precursor for betaine, on plasma homocysteine concentrations in healthy humans are unknown. If supplementation with choline or phosphatidylcholine, the form in which choline occurs in foods, lowers homocysteine concentrations, then extra intake of these compounds may lower cardiovascular disease risk in humans. Comparison: We compared the effects of supplementation with phosphatidylcholine to the effects of a placebo on fasting and post-methionine concentrations of plasma homocysteine in healthy men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | supplementation with phosphatidylcholine |
Timeline
- Start date
- 2003-05-01
- Completion
- 2003-07-01
- First posted
- 2005-01-26
- Last updated
- 2005-06-24
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00102232. Inclusion in this directory is not an endorsement.